Page last updated: 2024-09-04

phosphorodithioic acid and oblimersen

phosphorodithioic acid has been researched along with oblimersen in 2 studies

Compound Research Comparison

Studies
(phosphorodithioic acid)
Trials
(phosphorodithioic acid)
Recent Studies (post-2010)
(phosphorodithioic acid)
Studies
(oblimersen)
Trials
(oblimersen)
Recent Studies (post-2010) (oblimersen)
1290511954027

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benimetskaya, L; Colombini, M; Lai, JC; Miller, P; Stein, CA; Tan, W1
Amartey, J; Noe, CR; Stessl, M; Winkler, J1

Other Studies

2 other study(ies) available for phosphorodithioic acid and oblimersen

ArticleYear
A pharmacologic target of G3139 in melanoma cells may be the mitochondrial VDAC.
    Proceedings of the National Academy of Sciences of the United States of America, 2006, May-09, Volume: 103, Issue:19

    Topics: Base Sequence; Cell Line, Tumor; Cytochromes c; Humans; Ion Channel Gating; Melanoma; Mitochondria; Mitochondrial Membranes; Oligonucleotides; Phosphates; Thionucleotides; Voltage-Dependent Anion Channels

2006
Off-target effects related to the phosphorothioate modification of nucleic acids.
    ChemMedChem, 2010, Aug-02, Volume: 5, Issue:8

    Topics: Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Electrophoresis, Gel, Two-Dimensional; Humans; Intercellular Adhesion Molecule-1; Lactates; Melanoma; Oligonucleotides, Antisense; Phosphates; Proto-Oncogene Proteins c-bcl-2; RNA Interference; RNA, Small Interfering; Thionucleotides

2010